The expression levels of risk factors IL4I1, SMS, and ADI1 in high-grade gliomas were higher than those in lower‐grade gliomas, while the protein expression levels of protective factor GCLC, MSRB2, MTAP and MPST were exactly the opposite (Fig. S2). This evidence concerns the gene MSRB2 and glioma.